DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Leukocyte transendothelial migration	R-HSA-8950732	map04670	tribenoside	196122	drug-path
Non-small cell lung cancer	R-HSA-5619066	map05223	tribenoside	196122	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	roxarsone	5104	drug-path
Hematopoietic cell lineage	R-HSA-173752	map04640	roxarsone	5104	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	roxarsone	5104	drug-path
Antigen processing and presentation	R-HSA-1236975	map04612	roxarsone	5104	drug-path
Olfactory transduction	R-HSA-9751605	map04740	roxarsone	5104	drug-path
Cell adhesion molecules (CAMs)	R-HSA-1031690	0	roxarsone	5104	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	roxarsone	5104	drug-path
Asthma	R-HSA-444620	map05310	roxarsone	5104	drug-path
Allograft rejection	R-HSA-9679028	map05330	roxarsone	5104	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	roxarsone	5104	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	levocabastine	54385	drug-path
ECM-receptor interaction	R-HSA-373711	map04512	levocabastine	54385	drug-path
RNA polymerase	R-HSA-73864	map03020	levocabastine	54385	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	levocabastine	54385	drug-path
Olfactory transduction	R-HSA-9751605	map04740	levocabastine	54385	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	lansoprazole	3883	drug-path
Type II diabetes mellitus	R-HSA-2127377	map04930	lansoprazole	3883	drug-path
Gap junction	R-HSA-190861	map04540	triprolidine	5282443	drug-path